Tewis Bouwmeester is the Site Head of the Chemical Biology & Therapeutics department in Basel. His research interests are stem cell biology and regenerative medicine, epigenetics and neuroscience. Tewis joined the Novartis Institutes for BioMedical Research (NIBR) in May 2008 from the biotech company Cellzome, where he was VP, Biology & Research Alliances. Before that, Tewis was a faculty member at the European Molecular Biology Laboratory in Heidelberg. Tewis received his PhD in Biochemistry from the Free University in Amsterdam and completed his postdoctoral work at the HHMI at UCLA in Los Angeles, working in the field of developmental neurobiology.